Inpart: Unifying Biotech Collaboration Through Strategic Integration

Inpart is a unified digital platform for biopharma partnering, created through the rebranding and integration of Inova, IN-PARTDealroom has a profile for this one. Try Dealroom →, and LabiotechDealroom has a profile for this one. Try Dealroom →.

The transformation began in 2022, when Inova, a French company specialising in partnering software for the life sciences, acquired IN-PART, a UK-based platform founded in 2014 that connects academic researchers with industry partners.

In the same year, Inova also acquired Labiotech, a leading European biotech media outlet established in 2014.

Following these acquisitions, the company underwent a strategic rebranding in 2024, consolidating its services and expertise under the new name Inpart.

The platform now combines digital tools for managing partnerships, a matchmaking network for research-industry collaboration, and industry news and analysis.

Inpart aims to streamline the process of finding partners, managing alliances, and accessing biotech insights, supporting innovation and commercialization across the global life sciences sector.

Sources:
Clipperton
Labiotech
Tech.eu
ASTP

J.V.